Results 91 to 100 of about 20,731 (163)

Co-Administration Dosing of Ceftazidime-Avibactam and Aztreonam in Patients with Varying Renal Function for Carbapenem-Resistant Enterobacterales Infections via Monte Carlo Simulation. [PDF]

Infect Chemother
Hemapanpairoa J, Saelim W, Changpradub D, Santimaleeworagun W.   +3 more
europepmc   +1 more source

Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants. [PDF]

Antimicrob Agents Chemother
Morita J, Hida N, Yonemura T, Yamazaki T, Sato H, Sumiya M, Takaya R, Kumagai Y, Uchida N.   +8 more
europepmc   +1 more source

Longer durations of piperacillin/tazobactam treatment cause more prolonged alteration of colonization resistance in mice. [PDF]

PLoS One
Hausman BS, Kaple CE, Cadnum JL, Memic S, Sangwan N, Donskey CJ.   +5 more
europepmc   +1 more source

Evaluation of effectiveness of a regional remote antimicrobial stewardship program. [PDF]

Antimicrob Steward Healthc Epidemiol
Grubish T, Schmidt D, Badaglialacqua S, Warner S, Morris D, Destache C, El-Herte R, Koren M.   +7 more
europepmc   +1 more source

Overcoming resistance barriers: Using the salvage therapy of Ceftazidime-Avibactam and Aztreonam for difficult-to-treat gram-negative infections at a tertiary care hospital in Karachi-A retrospective cohort pilot. [PDF]

Pak J Med Sci
Sarfaraz S, Zafar SM, Siddiqui NA, Hanif MH, Hussain Z.   +4 more
europepmc   +1 more source

Ceftazidime-Avibactam/Aztreonam Combination for the Treatment of Carbapenem-resistant Klebsiella pneumoniae-induced Osteomyelitis: A Case Series with Review of Literature. [PDF]

J Orthop Case Rep
Gupta A, Chaudhari H, Kumar R, Mishra AK, Aggarwal N, Saran A.   +5 more
europepmc   +1 more source

Use of Aztreonam-avibactam for infections caused by MBL-producing <i>Enterobacterales</i>. [PDF]

New Microbes New Infect
Medioli F, Bavaro DF, Cento V, Scuderi C, Tordato F, Casana M, Diella L, Cilli A, Morelli P, Varisco B, Della Porta MG, Carlo-Stella C, Vanoni M, Costantini E, Bramanti S, Cecconi M, Bussini L, Bartoletti M.   +17 more
europepmc   +1 more source

Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study. [PDF]

Open Forum Infect Dis
Cordova E, Balbuena JP, Mykietiuk A, Farina J, Gañete M, Scapellato P, Lespada MI, Nannini E, Contreras R, Cunto E, Barcelona L, Pasteran F, Salgueira C, Hojman M, Blanco M, Lopez Alegre H, Cox Fernandez WE, Ezcurra C, Godoy D, Biglia MA, Lopez Furst MJ, Mendez G, Aguirre Rios MF, Altclas J, Sanchez C, Stryjewski ME.   +25 more
europepmc   +1 more source

Successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> and Enterobacterales coinfection with sulbactam-durlobactam combined with aztreonam: a case report. [PDF]

AME Case Rep
Yang S, Cheng Z, Liu Y, Ni L, Wei C.
europepmc   +1 more source

Comparative <i>in vitro</i> activity of aztreonam-avibactam and aztreonam plus ceftazidime-avibactam against <i>Stenotrophomonas maltophilia</i> complex. [PDF]

Antimicrob Agents Chemother
Kunz Coyne AJ, Gray R, Gonnabathula P, May ES, Tamma PD, Do A.   +5 more
europepmc   +1 more source